A Design of mRNA-Based COVID-19 Vaccine Through Fuzzy Neural Network

Area of Science:

• Vaccinology
• Molecular Biology
• Bioinformatics

Background:

• The development of messenger RNA (mRNA) vaccines revolutionized vaccinology, offering a new approach to infectious disease prevention.
• Emerging SARS-CoV-2 variants possess numerous genetic mutations, particularly on the spike protein, potentially evading existing vaccine architectures.
• Current vaccine design often relies on fixed structures, which may not effectively address the rapid evolution of viral mutations.

Purpose of the Study:

• To propose a novel, modular RNA-based vaccine for COVID-19 capable of adapting to SARS-CoV-2 variants.
• To enhance vaccine efficacy by collectively analyzing mutations using epitope perception and optimizing the vaccine design.
• To address the challenge of viral evolution in vaccine development through an innovative modular approach.

Main Methods:

• A four-module vaccine design framework was proposed: SARS-CoV-2 profile, mRNA-based vaccine design, interaction box, and neural codon optimization.
• Epitope perception was utilized to analyze and collectively address mutations across different SARS-CoV-2 variants.
• Neural codon optimization was employed to refine the mRNA vaccine sequence for improved performance.

Main Results:

• The proposed modular RNA vaccine demonstrated high levels of protection against a range of SARS-CoV-2 mutations.
• The vaccine achieved a notable 78% protection rate against the challenging New3 mutation with two doses.
• Comparative analysis indicated superior performance against various virus mutations compared to conventional approaches.

Conclusions:

• The developed modular RNA vaccine offers a promising strategy for combating evolving SARS-CoV-2 variants.
• This approach enhances vaccine adaptability and efficacy in the face of viral genetic diversity.
• The findings suggest a potential advancement in mRNA vaccine technology for future pandemic preparedness.